No Data
No Data
Pfizer Options Spot-On: On July 24th, 112.4K Contracts Were Traded, With 2.77 Million Open Interest
Pfizer, BioNTech Covid Vaccine Receives Approval in UK
Pfizer/ BioNTech Win U.K. Nod for JN.1-adjusted COVID-19 Shot
New Win for Pfizer (NYSE:PFE) Provides Slight Boost
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
Express News | UK's MHRA Approved An Adapted Pfizer/BioNTech Covid-19 Vaccine (Comirnaty) That Targets The JN.1 Covid-19 Subvariant; Four Forms Of This Adapted Comirnaty JN.1 Vaccine Have Been Approved
loading...
No Data